Navigation Links
Zimmer Holdings to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference
Date:5/27/2011

WARSAW, Ind., May 27, 2011 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal care, announced that it will be participating in the Goldman Sachs 32nd Annual Global Healthcare Conference at the Terranea Resort in Rancho Palos Verdes, California, on June 7, 2011, at 8:40 a.m. Pacific Time.

A live webcast of the presentation can be accessed via Zimmer's Investor Relations website at http://cc.talkpoint.com/gold006/060711a_lr/?entity=2_7US6RE7.  The webcast will be archived for replay following the conference.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.  Zimmer's 2010 sales were approximately $4.2 billion.  The Company is supported by the efforts of more than 8,000 employees worldwide.

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management.  Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially.  For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary statement is applicable to all forward-looking statements contained in this document.


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmers Trabecular Metal(TM) Technology
2. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2009 Results
3. Zimmer Reports Fourth Quarter and 2009 Financial Results
4. Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes
5. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Fourth Quarter and Full-Year 2009 Results
6. Zimmer Holdings to Present at 21st Annual Piper Jaffray Health Care Conference
7. Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer
8. Zimmer Holdings to Present at Cowen & Company 30th Annual Health Care Conference
9. Zimmer Natural Knee Celebrates 25 Years of Excellence
10. Zimmer Holdings to Present at Bank of America Merrill Lynch 2010 Health Care Conference
11. Zimmer Holdings to Present at Bairds 2010 Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... , Sept. 7, 2017  Eli Lilly ... announced actions to streamline operations to more efficiently ... improve its cost structure. Global workforce reductions, including ... are expected to impact approximately 3,500 positions. ... company expects annualized savings of approximately $500 million ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... that Mike Rice , President and CEO, will be ... Rodman & Renshaw 19 th Annual Global ... time (12:25 p.m. Pacific time). The conference is being held ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
Breaking Medicine Technology:
(Date:9/25/2017)... , ... September 25, 2017 , ... ... an international competition, were announced on Friday, September 22 during a gala event ... human resources professionals, teams, achievements and HR-related products and suppliers who help to ...
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... ... further expand its Portable, Continuous, Miniature, and Modular (PCMM) collaboration with Pfizer and ... POD-based Oral Solid Dosage line. The new PODs will provide tablet coating capability ...
(Date:9/25/2017)... ... 2017 , ... Lean Management techniques applied to the laboratory ... for laboratory weighing is designed to help laboratory personnel strengthen lab processes ... on downstream processes. , If a problem is detected, the "First-Defect-Stop" procedure should ...
(Date:9/25/2017)... ... , ... The Asset Tracking and Temperature monitoring system works in conjunction with ... bar code of the product and lot ID then scanning the HPP basket and ... automatically generated and exception alerts sent out to designated individuals. , "In recognizing the ...
(Date:9/25/2017)... Seoul, South Korea (PRWEB) , ... September 25, 2017 , ... ... please those looking for a one-stop shop for the hottest Korean cosmetics and fashion ... natural move for a company that’s already well-known for the great offerings that allow ...
Breaking Medicine News(10 mins):